PortfoliosLab logoPortfoliosLab logo

Documentation

Upgrade your plan

AbbVie Inc. (ABBV) Sharpe Ratio: 0.79

Equity · Currency in USD · Last updated Jun 3, 2026

AbbVie Inc is an American multinational biopharmaceutical company based in North Chicago, Illinois. It was created in 2013 as a spin-off of Abbott Laboratories. AbbVie is focused on developing and marketing advanced therapies for severe and chronic conditions, emphasizing oncology, immunology, and virology.

ABBV's Sharpe Ratio of 0.79 indicates that for each unit of volatility, it generates 0.79 units of excess return above the risk-free rate. The ratio is calculated using historical daily returns over the past 12 months (as of Jun 3, 2026).

Sharpe uses total volatility (standard deviation) which includes both upside and downside price movements, making it useful for comparing risk-adjusted returns across different assets.

ABBV Sharpe Ratio Rank

ABBV Sharpe Ratio Rank: 65.766
Above Average

ABBV ranks above 65.7% of all investments in our database based on Sharpe Ratio over the past 12 months, indicating above-average returns relative to volatility. Securities are ranked from 0 (worst) to 100 (best).

What moves the rank

  • Strong returns with low total volatility → Higher rank
  • High volatility (both upside and downside) → Lower rank
  • Consistent returns → Higher rank than volatile returns of same magnitude
  • Sharp drawdowns increase volatility → Lower rank

What you can do with this information

  • Above-average risk-adjusted returns with room for improvement
  • Compare against category peers to gauge relative positioning
  • Monitor for movement toward top tier or decline toward median
  • Consider pairing with top-tier holdings to improve portfolio efficiency

ABBV Sharpe Ratio Market Positioning

The chart shows ABBV's Sharpe Ratio relative to all stocks on our platform, with color zones indicating percentile rankings. Higher ratios indicate better risk-adjusted returns.

  • Red zone (bottom 25%): -0.37 or lower
  • Yellow zone (middle 50%): -0.37 to 1.19
  • Green zone (top 25%): 1.19 or higher
  • Top 1%: 6.05+
  • Median: 0.27 — half of all investments score higher

How it compares to other similar stocks

The table compares AbbVie Inc.'s Sharpe Ratio with other stocks in the Drug Manufacturers - General industry across multiple time periods, showing how ABBV's risk-adjusted performance compares to industry peers.

Data shows 1-, 5-, and 10-year periods, plus each stock's all-time average, as of Jun 3, 2026.

SymbolName1Y Sharpe Ratio5Y Sharpe Ratio10Y Sharpe RatioAll Time Sharpe Ratio
JNJJohnson & Johnson2.83
MRKMerck & Co., Inc.2.14
HAWPYHaw Par Corporation Ltd ADR1.60
BIIBBiogen Inc.1.34
NVSNovartis AG1.32
OTSKYOtsuka Holdings Co Ltd ADR1.30
ALPMYAstellas Pharma Inc1.30
LLYEli Lilly and Company1.15
OPHLYOno Pharmaceutical Co Ltd1.09
AZNAstraZeneca PLC1.07
ABBVAbbVie Inc.0.79

S&P 500 Index

How to choose period

Historical Sharpe Ratio

The chart shows ABBV's rolling Sharpe ratio over time compared to your chosen benchmark. Rising trends indicate improving returns relative to total volatility, while declining trends may signal deteriorating risk-adjusted performance or increased volatility. Use multiple timeframes to distinguish short-term fluctuations from long-term patterns.

Identify market cycles by observing when ABBV consistently outperforms (line above benchmark), underperforms (below benchmark), or aligns with the benchmark.

Loading charts...

Sharpe Ratio Calculator

How does ABBV fit in your portfolio?

Add your other holdings to see your portfolio's Sharpe Ratio and find out.

Analyze Your Portfolio